We just launched our Seed 3 crowdfunding raise on StartEngine®. This is your opportunity to support the development of RSBT-001 for respiratory diseases characterized by pulmonary inflammation, including Chronic Obstruction Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF).